I just sold some tradable shares yesterday, Charts say sell to me for the first time in some time. I did buy those tradable on the way up during pullbacks... My core position is at a much lower pps. Those I'll keep. If I'm wrong, I'm planning to buy back this week anyway in anticipation of the EMA. Shouldn't miss too much in light of overall mkt trend.
UK officials are resigning not happy...BIO hit a wall two days ago, looked like it was falling off a cliff. Then some "holy reversal" took place around 10:30 am, (look at a 5 day chart on LABU), and the whole sector went up as did the mkt in general...EXEL was actually not following the rest of BIO at the time and managing small gains. I still anticipate EXEL takes a hit with the rest of the mkt today, but also expect it to rebound earlier than most. Don't have any Idea of the timing of rebound.
Right now a lot of big pharma is searching for revenue generators as patient expiration are affecting bottom line. Not playing for a buyout, think EXEL has a ways to go north without that factor. But oncology space is the new promise land for all these groups...and EXEL is sitting on a gold nugget.